Inventor · disambiguated record
Byung-Zun Ahn
Also filed as: AHN BYUNG-ZUN
6 granted patents·1 pending application·9 citations·filing 1994–2019
73Inventor score
Top patents by PatentIndex Score
7 records- 0156US6552035B2Composition for inducing smoking cessation comprising alkaloids from Radix ipecauanhaeHWA MOK PARK·Filed 2001·Granted Apr 22, 2003·3 cites·12 claims
- 0254US2004082528A1Use of hederagenin 3-O-alpha-L-rhamnopyranosyl((1-2)-[Beta-D-glucopyranosyl(1-4)]-alpha-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumorsFiled 2003·Application pending·0 cites
- 0352US6894075B24′-demethyl-4′-O-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the sameFiled 2001·Granted May 17, 2005·1 cites·6 claims
- 0451US7682638B2Use of hederagenin 3-O-α-L-rhamnopyranosyl(1-2)-[β-D-glucopyranosyl(1-4)]-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumorsKIM SONG-BAE·Filed 2005·Granted Mar 23, 2010·0 cites·2 claims
- 0547US8075923B2Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumorsKIM SONG-BAE·Filed 2010·Granted Dec 13, 2011·0 cites·6 claims
- 0643US5696276AProcess for preparing 5,8-dihydroxynaphthoquinone derivatives, novel 5,8-dihydroxynaphthoquinone derivatives and their use as anticancer agentKUHNIL PHARMACEUTICAL CO LTD·Filed 1994·Granted Dec 9, 1997·5 cites·8 claims
- 0735US11951145B2Composition for preventing or treating cancer comprising extracts of anemone raddeana, Lonicera species, and aralia elata containing high concentration of antitumor saponins, and method for preparing sameBACK JU YOUN·Filed 2019·Granted Apr 9, 2024·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Byung-Zun Ahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →